{
  "company_id": "immatics",
  "company_name": "Immatics",
  "generated_at": "2026-02-06T05:35:16Z",
  "kpis": {
    "assets_total": 3,
    "assets_with_trials": 2,
    "trials_total": 2
  },
  "top_assets": [
    {
      "asset_id": 19,
      "asset_name": "IMA402 + ICI",
      "highest_stage": "Phase 1",
      "linked_trials_count": 1,
      "indications": [
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 20,
      "asset_name": "IMA401",
      "highest_stage": "Phase 1",
      "linked_trials_count": 1,
      "indications": [
        {
          "indication": "HNSCC, sqNSCLC, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 18,
      "asset_name": "IMA402",
      "highest_stage": "Phase 1",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        }
      ]
    }
  ],
  "recent_changes": [
    {
      "event_type": "trials_ingested",
      "created_at": "2026-02-06 05:35:16.213297",
      "occurred_at": "2026-02-06 05:35:16.213297",
      "payload": {
        "trials_seen": 2,
        "inserted": 2,
        "updated": 0,
        "status_changed": 0,
        "bad_aliases": 0
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-06 05:35:15.565066",
      "occurred_at": "2026-02-06 05:35:15.565066",
      "payload": {
        "nct_id": "NCT05359445",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_added",
      "created_at": "2026-02-06 05:35:15.557560",
      "occurred_at": "2026-02-06 05:35:15.557560",
      "payload": {
        "nct_id": "NCT05359445",
        "title": "A Phase Ia/Ib First-In-Human Clinical Trial to Evaluate the Safety, Tolerability and Initial Anti-Tumor Activity of IMA401, a Bispecific T Cell Engaging Receptor Molecule (TCER\u00ae), as Monotherapy or in Combination With Checkpoint Inhibitor in Patients With Recurrent and/or Refractory Solid Tumors."
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-06 05:35:15.206940",
      "occurred_at": "2026-02-06 05:35:15.206940",
      "payload": {
        "nct_id": "NCT05958121",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_added",
      "created_at": "2026-02-06 05:35:15.193478",
      "occurred_at": "2026-02-06 05:35:15.193478",
      "payload": {
        "nct_id": "NCT05958121",
        "title": "A Phase I/II First-In-Human Clinical Trial to Evaluate the Safety, Tolerability and Anti-Tumor Activity of IMA402, a Bispecific TCER\u00ae Targeting PRAME, in Patients With Recurrent and/or Refractory Solid Tumors"
      }
    },
    {
      "event_type": "pipeline_ingested",
      "created_at": "2026-02-06 05:34:58.557436",
      "occurred_at": "2026-02-06 05:34:58.557436",
      "payload": {
        "pipeline_page": "https://immatics.com/our-pipeline/",
        "pipeline_image": "https://immatics.com/wp-content/uploads/2025/12/20251112_IMTX_pipeline_v3-scaled.png",
        "assets_seen": 5
      }
    },
    {
      "event_type": "asset_indication_added",
      "created_at": "2026-02-06 05:34:58.554154",
      "occurred_at": "2026-02-06 05:34:58.554154",
      "payload": {
        "asset": "Undisclosed cell therapy",
        "indication": "Undisclosed",
        "stage": "Preclinical",
        "therapeutic_area": "Oncology"
      }
    },
    {
      "event_type": "asset_added",
      "created_at": "2026-02-06 05:34:58.552046",
      "occurred_at": "2026-02-06 05:34:58.552046",
      "payload": {
        "asset": "Undisclosed cell therapy"
      }
    },
    {
      "event_type": "asset_indication_added",
      "created_at": "2026-02-06 05:34:58.544028",
      "occurred_at": "2026-02-06 05:34:58.544028",
      "payload": {
        "asset": "Undisclosed bispecific",
        "indication": "Undisclosed",
        "stage": "Preclinical",
        "therapeutic_area": "Oncology"
      }
    },
    {
      "event_type": "asset_added",
      "created_at": "2026-02-06 05:34:58.542110",
      "occurred_at": "2026-02-06 05:34:58.542110",
      "payload": {
        "asset": "Undisclosed bispecific"
      }
    },
    {
      "event_type": "asset_indication_added",
      "created_at": "2026-02-06 05:34:58.533720",
      "occurred_at": "2026-02-06 05:34:58.533720",
      "payload": {
        "asset": "IMA401",
        "indication": "HNSCC, sqNSCLC, other solid cancers",
        "stage": "Phase 1",
        "therapeutic_area": "Oncology"
      }
    },
    {
      "event_type": "asset_added",
      "created_at": "2026-02-06 05:34:58.531739",
      "occurred_at": "2026-02-06 05:34:58.531739",
      "payload": {
        "asset": "IMA401"
      }
    },
    {
      "event_type": "asset_indication_added",
      "created_at": "2026-02-06 05:34:58.523256",
      "occurred_at": "2026-02-06 05:34:58.523256",
      "payload": {
        "asset": "IMA402 + ICI",
        "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
        "stage": "Phase 1",
        "therapeutic_area": "Oncology"
      }
    },
    {
      "event_type": "asset_added",
      "created_at": "2026-02-06 05:34:58.521324",
      "occurred_at": "2026-02-06 05:34:58.521324",
      "payload": {
        "asset": "IMA402 + ICI"
      }
    },
    {
      "event_type": "asset_indication_added",
      "created_at": "2026-02-06 05:34:58.508577",
      "occurred_at": "2026-02-06 05:34:58.508577",
      "payload": {
        "asset": "IMA402",
        "indication": "Melanoma, gynecologic cancers, other solid cancers",
        "stage": "Phase 1",
        "therapeutic_area": "Oncology"
      }
    },
    {
      "event_type": "asset_added",
      "created_at": "2026-02-06 05:34:58.505730",
      "occurred_at": "2026-02-06 05:34:58.505730",
      "payload": {
        "asset": "IMA402"
      }
    }
  ],
  "trials": [
    {
      "nct_id": "NCT05958121",
      "overall_status": "RECRUITING",
      "phase": "PHASE1,PHASE2",
      "last_update_posted": "2025-11-18",
      "linked_assets": [
        "IMA402 + ICI"
      ]
    },
    {
      "nct_id": "NCT05359445",
      "overall_status": "RECRUITING",
      "phase": "PHASE1",
      "last_update_posted": "2025-09-09",
      "linked_assets": [
        "IMA401"
      ]
    }
  ]
}